NCT05493566 2026-02-12
Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer
Emory University
Phase EARLY_PHASE1 Recruiting
Emory University
Rutgers, The State University of New Jersey
Roger Williams Medical Center
Cancer Research UK
Georgetown University